...
首页> 外文期刊>Journal of biomedical materials research. Part B, Applied biomaterials. >The new adhesion prophylaxis membrane A-part--from in vitro testing to first in vivo results.
【24h】

The new adhesion prophylaxis membrane A-part--from in vitro testing to first in vivo results.

机译:新的预防粘膜A部分-从体外测试到首次体内结果。

获取原文
获取原文并翻译 | 示例
           

摘要

INTRODUCTION: Formation of postoperative intra-abdominal adhesions is a severe problem in surgery. Apart from standard surgical procedures, a variety of different substances is available to prevent adhesions, but no universal method has been developed so far. A membrane consisting of polyvinyl alcohol (PVA) and carboxymethylcellulose (CMC) has been demonstrated to be antiadhesive. Here, the in vitro testing and first in vivo results in a rabbit sidewall model are reported. MATERIALS AND METHODS: A-part membrane contains a PVA/CMC mixture in a thickness of 40 microm. The composition, dissolution, tensile strength, and elasticity were examined to characterize the membrane in vitro. Experiments in vivo were carried out using a 'rabbit sidewall model' in which a standardized peritoneal trauma was covered with a 5 x 6 cm A-part membrane. Adhesion formation in A-part-treated animals was compared with that in Adept (15 mL/kg body weight) and untreated controls. RESULTS: An 80/20 PVA/CMC mixture forms a stable, elastic, transparent membrane, which can easily be placed intraoperatively. The dissolution shows a half-life of about 2 weeks [day 15: (45.1 +/- 4.9)% SD], which affords good adhesion protection during the initial critical phase of adhesion formation. In wet conditions, the membrane follows abdominal movements without tearing (tensile strength 5.0 +/- 4.2 N/cm SD; elasticity 29.5%). In a rabbit sidewall model, A-part membrane significantly reduced adhesion development by (83.1 +/- 31.5)% SD compared with the control and the Adept group (p < 0.001). CONCLUSION: The properties of the A-part membrane suggest that it may be useful as an antiadhesive in surgery. A-part is effective in in vivo testing as determined in a rabbit sidewall model.
机译:引言:术后腹腔内粘连的形成是外科手术中的严重问题。除了标准的外科手术程序外,还可以使用多种不同的物质来防止粘连,但迄今为止尚未开发出通用的方法。由聚乙烯醇(PVA)和羧甲基纤维素(CMC)组成的膜已被证明具有抗粘性。在此,报道了兔侧壁模型的体外测试和首次体内结果。材料和方法:A部分膜包含厚度为40微米的PVA / CMC混合物。检查了组成,溶解度,拉伸强度和弹性以表征体外膜。使用“兔子侧壁模型”进行体内实验,在该模型中,标准腹膜外伤覆盖有5 x 6 cm A部分膜。将A部分处理的动物与Adept(15mL / kg体重)和未处理的对照组的粘着形成进行了比较。结果:80/20 PVA / CMC混合物形成稳定,弹性,透明的膜,可在术中轻松放置。溶解显示出约2周的半衰期[第15天:(45.1 +/- 4.9)%SD],在粘附形成的最初关键阶段提供了良好的粘附保护。在潮湿条件下,该膜可跟随腹部运动而不会撕裂(抗张强度5.0 +/- 4.2 N / cm SD;弹性29.5%)。在兔侧壁模型中,与对照组和Adept组相比,A部膜明显减少了(83.1 +/- 31.5)%SD的粘连形成(p <0.001)。结论:A-部分膜的性质表明它可能在外科手术中用作抗粘剂。如兔子侧壁模型中所确定的,A部分在体内测试中是有效的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号